Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6374.00 | 6615.25 | 0.9635 | 0.9516 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6679.00 | 6615.25 | 1.0096 | 1.0127 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6748.00 | 6615.25 | 1.0201 | 1.0264 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 5000.00 | 2314.91 | 5961.00 | 6615.25 | 0.9011 | 0.8671 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6692.00 | 6615.25 | 1.0116 | 1.0153 | |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6584.00 | 6615.25 | 0.9953 | 0.9938 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6532.00 | 6615.25 | 0.9874 | 0.9834 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6593.00 | 6615.25 | 0.9966 | 0.9956 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 187.00 | 200.75 | 0.9315 | 0.9122 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 236.00 | 200.75 | 1.1756 | 1.2155 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 156.25 | 67.09 | 88.00 | 200.75 | 0.4384 | 0.1872 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 239.00 | 200.75 | 1.1905 | 1.2332 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 335.00 | 200.75 | 1.6687 | 1.7649 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 67.09 | 188.00 | 200.75 | 0.9365 | 0.9187 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 156.25 | 67.09 | 172.00 | 200.75 | 0.8568 | 0.8138 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 156.25 | 67.09 | 206.00 | 200.75 | 1.0262 | 1.0329 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 287.00 | 200.75 | 1.4296 | 1.5073 | |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 208.00 | 200.75 | 1.0361 | 1.0454 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 156.25 | 67.09 | 190.00 | 200.75 | 0.9465 | 0.9316 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 224.00 | 200.75 | 1.1158 | 1.1435 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 240.00 | 200.75 | 1.1955 | 1.2391 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 156.25 | 67.09 | 67.00 | 200.75 | 0.3338 | -0.0009 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 156.25 | 67.09 | 233.00 | 200.75 | 1.1606 | 1.1976 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 156.25 | 67.09 | 128.00 | 200.75 | 0.6376 | 0.5046 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 156.25 | 67.09 | 138.00 | 200.75 | 0.6874 | 0.5779 |